SEER, INC. Research and Development Expense
SEER, INC. (SEER) reported Research and Development Expense of $8.21 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-11
- SEER, INC. research and development expense for the quarter ending 2026-06-30 was $8.21M, a 31.51% decline year-over-year.
- SEER, INC. research and development expense for the quarter ending 2026-03-31 was $8.81M, a 22.41% decline year-over-year.
- SEER, INC. research and development expense for the quarter ending 2025-12-31 was $9.74M, a 22.80% decline year-over-year.
- SEER, INC. research and development expense for the quarter ending 2025-09-30 was $10.80M, a 16.73% decline year-over-year.
- SEER, INC. research and development expense for fiscal 2025 was $43.87M, a 13.27% decline from fiscal 2024.
- SEER, INC. research and development expense for fiscal 2024 was $50.59M, a 4.59% decline from fiscal 2023.
- SEER, INC. research and development expense for fiscal 2023 was $53.02M, a 15.77% increase from fiscal 2022.
- SEER, INC. research and development expense for fiscal 2022 was $45.80M, a 57.26% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.21M 10-Q · filed 2026-08-11 | $17.02M 10-Q · filed 2026-08-11 | $26.76M derived: sum of 3 quarters · filed 2026-08-11 | $37.55M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $8.81M 10-Q · filed 2026-05-13 | $18.55M derived: sum of 2 quarters · filed 2026-05-13 | $29.34M derived: sum of 3 quarters · filed 2026-05-13 | $41.33M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $9.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $20.54M derived: sum of 2 quarters · filed 2026-03-02 | $32.52M derived: sum of 3 quarters · filed 2026-08-11 | $43.87M 10-K · filed 2026-03-02 |
| 2025-09-30 | $10.80M 10-Q · filed 2025-11-06 | $22.78M derived: sum of 2 quarters · filed 2026-08-11 | $34.13M 10-Q · filed 2025-11-06 | $46.75M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $11.98M 10-Q · filed 2026-08-11 | $23.34M 10-Q · filed 2026-08-11 | $35.95M derived: sum of 3 quarters · filed 2026-08-11 | $48.92M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $11.35M 10-Q · filed 2026-05-13 | $23.97M derived: sum of 2 quarters · filed 2026-05-13 | $36.94M derived: sum of 3 quarters · filed 2026-05-13 | $49.67M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $12.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $25.59M derived: sum of 2 quarters · filed 2026-03-02 | $38.32M derived: sum of 3 quarters · filed 2026-03-02 | $50.59M 10-K · filed 2026-03-02 |
| 2024-09-30 | $12.97M 10-Q · filed 2025-11-06 | $25.70M derived: sum of 2 quarters · filed 2025-11-06 | $37.97M 10-Q · filed 2025-11-06 | $49.13M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $12.73M 10-Q · filed 2025-08-06 | $25.00M 10-Q · filed 2025-08-06 | $36.16M derived: sum of 3 quarters · filed 2025-08-06 | $49.40M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $12.27M 10-Q · filed 2025-05-13 | $23.43M derived: sum of 2 quarters · filed 2025-05-13 | $36.66M derived: sum of 3 quarters · filed 2025-05-13 | $50.81M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $11.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $24.40M derived: sum of 2 quarters · filed 2025-03-03 | $38.55M derived: sum of 3 quarters · filed 2025-03-03 | $53.02M 10-K · filed 2025-03-03 |
| 2023-09-30 | $13.23M 10-Q · filed 2024-11-06 | $27.38M derived: sum of 2 quarters · filed 2024-11-06 | $41.85M 10-Q · filed 2024-11-06 | $54.48M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $14.15M 10-Q · filed 2024-08-08 | $28.62M 10-Q · filed 2024-08-08 | $41.25M derived: sum of 3 quarters · filed 2024-08-08 | $52.82M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $14.47M 10-Q · filed 2024-05-08 | $27.10M derived: sum of 2 quarters · filed 2024-05-08 | $38.67M derived: sum of 3 quarters · filed 2024-05-08 | $49.54M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $12.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | $24.19M derived: sum of 2 quarters · filed 2024-03-04 | $35.06M derived: sum of 3 quarters · filed 2024-03-04 | $45.80M 10-K · filed 2024-03-04 |
| 2022-09-30 | $11.56M 10-Q · filed 2023-11-07 | $22.43M derived: sum of 2 quarters · filed 2023-11-07 | $33.17M 10-Q · filed 2023-11-07 | $41.38M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $10.87M 10-Q · filed 2023-08-08 | $21.61M 10-Q · filed 2023-08-08 | $29.82M derived: sum of 3 quarters · filed 2023-08-08 | $37.56M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $10.73M 10-Q · filed 2023-05-09 | $18.95M derived: sum of 2 quarters · filed 2023-05-09 | $26.69M derived: sum of 3 quarters · filed 2023-05-09 | $33.63M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $8.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $15.96M derived: sum of 2 quarters · filed 2023-03-06 | $22.89M derived: sum of 3 quarters · filed 2023-03-06 | $29.12M 10-K · filed 2023-03-06 |
| 2021-09-30 | $7.75M 10-Q · filed 2022-11-08 | $14.68M derived: sum of 2 quarters · filed 2022-11-08 | $20.91M 10-Q · filed 2022-11-08 | $26.33M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $6.93M 10-Q · filed 2022-08-09 | $13.16M 10-Q · filed 2022-08-09 | $18.58M derived: sum of 3 quarters · filed 2022-08-09 | $23.35M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $6.23M 10-Q · filed 2022-05-06 | $11.65M derived: sum of 2 quarters · filed 2022-05-06 | $16.41M derived: sum of 3 quarters · filed 2022-05-06 | $20.95M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $5.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $10.18M derived: sum of 2 quarters · filed 2022-03-01 | $14.72M derived: sum of 3 quarters · filed 2022-03-01 | $18.94M 10-K · filed 2022-03-01 |
| 2020-09-30 | $4.76M 10-Q · filed 2021-11-09 | $9.30M derived: sum of 2 quarters · filed 2021-11-09 | $13.52M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $4.54M 10-Q · filed 2021-08-12 | $8.76M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $4.22M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |